HOLLY THIBODEAUX: Open Payments
NPI 1104028554 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 35 payments from 13 companies in 2025. Trend: 2023 $851 · 2024 $442 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $177 |
| Teva Pharmaceuticals USA, Inc. | 6 | $123 |
| Novo Nordisk Inc | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Amgen Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: AUSTEDO XR, VRAYLAR, REXULTI, UBRELVY, Rybelsus, FASENRA, Korlym, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
